Biotech

All Articles

Wave surfs DMD effectiveness to regulators' doors, sending out stockpile

.Surge Lifestyle Sciences has fulfilled its own target in a Duchenne muscle dystrophy (DMD) study, p...

Sanofi plucks new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma crease, tak...

Achilles drops cell therapy system, braces for discharges after skipping 'business practicality' goals

.Achilles Therapies has shreded its own approach. The English biotech is actually quiting working on...

Aligos heralds phase 2 MASH gain, lowering liver excess fat as much as 46%

.Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction affiliated steatohepatitis...

Basilea ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work building brand new antifungals has gotten a significant boost coming f...

Capricor markets Europe rights to late-stage DMD treatment for $35M

.Possessing presently scooped up the USA civil rights to Capricor Rehabs' late-stage Duchenne muscle...

FDA junks adcomm for Applied's uncommon ailment drug

.After pushing back the choice date for Applied Rehabs' metabolic ailment medicine govorestat, the F...

Novo inks $600M NanoVation package to examine genetic medicines ex-liver

.Novo Nordisk is continuing its press into hereditary medications, agreeing to pay NanoVation Therap...

Innovent hyperlinks cytokine to colorectal cancer feedbacks

.Innovent Biologics has made the scenario that its gate inhibitor-cytokine combination healthy prote...

Merck, Daiichi ADC reaches objective in period 3 lung cancer research

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...